Prognostic impact of positive peritoneal cytology (POPEC) in gastric cancer: Multi-centre European retrospective cohort study

Objective: Positive peritoneal cytology is traditionally viewed as representative of metastatic disease and a poor prognostic factor. The objective of this multi-center study was to define the prognostic role of peritoneal cytology in curative gastrectomy, evaluate international variation in cytolog...

Descripción completa

Detalles Bibliográficos
Autores: Owen, Richard, Griffiths, Ewen A., Pera Román, Manuel, Dal Cero, Mariagiulia, Saunders, John
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2025
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:10230/72886
Acceso en línea:https://hdl.handle.net/10230/72886
http://dx.doi.org/10.1016/j.soi.2025.100145
Access Level:acceso abierto
Palabra clave:Peritoneal cytology
Surgical oncology
Gastric cancer
Peritoneal carcinomatosis
Hyperthermic intraperitoneal chemotherapy
HIPEC
Pressurised intraPeritoneal aerosolised chemotherapy
PIPAC
id ES_00dfbcedc47d7385b35fbaa5ef375a45
oai_identifier_str oai:recercat.cat:10230/72886
network_acronym_str ES
network_name_str España
repository_id_str
spelling Prognostic impact of positive peritoneal cytology (POPEC) in gastric cancer: Multi-centre European retrospective cohort studyOwen, RichardGriffiths, Ewen A.Pera Román, ManuelDal Cero, MariagiuliaSaunders, JohnPeritoneal cytologySurgical oncologyGastric cancerPeritoneal carcinomatosisHyperthermic intraperitoneal chemotherapyHIPECPressurised intraPeritoneal aerosolised chemotherapyPIPACObjective: Positive peritoneal cytology is traditionally viewed as representative of metastatic disease and a poor prognostic factor. The objective of this multi-center study was to define the prognostic role of peritoneal cytology in curative gastrectomy, evaluate international variation in cytology sampling, and assess the impact on positive peritoneal cytology yields. Methods: This was a multi-center international retrospective cohort study of 16 tertiary gastric cancer centers. Adult patients who underwent peritoneal lavage cytology at staging laparoscopy and subsequent gastrectomy between 2009 and 2023 were included. The primary outcome measure was overall survival at five years. Multivariable Cox regression provided hazard ratios (HRs) with 95% CIs, adjusted for relevant confounding factors. Results: 837 patients with no radiological or macroscopic M1 disease were included, with a mean age of 66 (IQR 58-73) and 71% were male. Non-distal gastric cancer was most common (47%), with 59% and 43% of tumors staged pT3/4 and pN2/3 respectively. 66 patients (7.9%) had positive cytology. Positive cytology was not associated with overall survival in multivariable analysis, controlled for stage and neoadjuvant treatment (HR=1.0; 95% CI 0.51-2.0). Higher T and N stages were associated with positive cytology (p < 0.001). The proportion of patients with positive cytology was variable, depending on how many quadrants were sampled. Conclusion: Positive peritoneal cytology with otherwise M0 disease was not associated with decreased survival after curative intent gastrectomy in this study, meaning prospective study is needed. The technique of performing peritoneal washings influenced cytology yield and thus must be standardized in a much-needed prospective evaluation of peritoneal cytology. Synopsis: The POPEC multicenter international retrospective cohort study included 837 patients receiving curative gastrectomy. This study showed the technique of performing peritoneal washings influenced cytology yield, however positive peritoneal cytology was not associated with decreased survival. Therefore, positive peritoneal cytology should not be considered an absolute contraindication to curatively intended gastrectomy.Elsevier2026202620252026info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttps://hdl.handle.net/10230/72886http://dx.doi.org/10.1016/j.soi.2025.100145https://hdl.handle.net/10230/72886reponame:Recercat. Dipósit de la Recerca de Catalunyainstname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)InglésSurgical Oncology Insight. 2025;2(3):100145© 2025 Published by Elsevier Inc. on behalf of Society of Surgical Oncology. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).http://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:recercat.cat:10230/728862026-05-29T05:05:01Z
dc.title.none.fl_str_mv Prognostic impact of positive peritoneal cytology (POPEC) in gastric cancer: Multi-centre European retrospective cohort study
title Prognostic impact of positive peritoneal cytology (POPEC) in gastric cancer: Multi-centre European retrospective cohort study
spellingShingle Prognostic impact of positive peritoneal cytology (POPEC) in gastric cancer: Multi-centre European retrospective cohort study
Owen, Richard
Peritoneal cytology
Surgical oncology
Gastric cancer
Peritoneal carcinomatosis
Hyperthermic intraperitoneal chemotherapy
HIPEC
Pressurised intraPeritoneal aerosolised chemotherapy
PIPAC
title_short Prognostic impact of positive peritoneal cytology (POPEC) in gastric cancer: Multi-centre European retrospective cohort study
title_full Prognostic impact of positive peritoneal cytology (POPEC) in gastric cancer: Multi-centre European retrospective cohort study
title_fullStr Prognostic impact of positive peritoneal cytology (POPEC) in gastric cancer: Multi-centre European retrospective cohort study
title_full_unstemmed Prognostic impact of positive peritoneal cytology (POPEC) in gastric cancer: Multi-centre European retrospective cohort study
title_sort Prognostic impact of positive peritoneal cytology (POPEC) in gastric cancer: Multi-centre European retrospective cohort study
dc.creator.none.fl_str_mv Owen, Richard
Griffiths, Ewen A.
Pera Román, Manuel
Dal Cero, Mariagiulia
Saunders, John
author Owen, Richard
author_facet Owen, Richard
Griffiths, Ewen A.
Pera Román, Manuel
Dal Cero, Mariagiulia
Saunders, John
author_role author
author2 Griffiths, Ewen A.
Pera Román, Manuel
Dal Cero, Mariagiulia
Saunders, John
author2_role author
author
author
author
dc.subject.none.fl_str_mv Peritoneal cytology
Surgical oncology
Gastric cancer
Peritoneal carcinomatosis
Hyperthermic intraperitoneal chemotherapy
HIPEC
Pressurised intraPeritoneal aerosolised chemotherapy
PIPAC
topic Peritoneal cytology
Surgical oncology
Gastric cancer
Peritoneal carcinomatosis
Hyperthermic intraperitoneal chemotherapy
HIPEC
Pressurised intraPeritoneal aerosolised chemotherapy
PIPAC
description Objective: Positive peritoneal cytology is traditionally viewed as representative of metastatic disease and a poor prognostic factor. The objective of this multi-center study was to define the prognostic role of peritoneal cytology in curative gastrectomy, evaluate international variation in cytology sampling, and assess the impact on positive peritoneal cytology yields. Methods: This was a multi-center international retrospective cohort study of 16 tertiary gastric cancer centers. Adult patients who underwent peritoneal lavage cytology at staging laparoscopy and subsequent gastrectomy between 2009 and 2023 were included. The primary outcome measure was overall survival at five years. Multivariable Cox regression provided hazard ratios (HRs) with 95% CIs, adjusted for relevant confounding factors. Results: 837 patients with no radiological or macroscopic M1 disease were included, with a mean age of 66 (IQR 58-73) and 71% were male. Non-distal gastric cancer was most common (47%), with 59% and 43% of tumors staged pT3/4 and pN2/3 respectively. 66 patients (7.9%) had positive cytology. Positive cytology was not associated with overall survival in multivariable analysis, controlled for stage and neoadjuvant treatment (HR=1.0; 95% CI 0.51-2.0). Higher T and N stages were associated with positive cytology (p < 0.001). The proportion of patients with positive cytology was variable, depending on how many quadrants were sampled. Conclusion: Positive peritoneal cytology with otherwise M0 disease was not associated with decreased survival after curative intent gastrectomy in this study, meaning prospective study is needed. The technique of performing peritoneal washings influenced cytology yield and thus must be standardized in a much-needed prospective evaluation of peritoneal cytology. Synopsis: The POPEC multicenter international retrospective cohort study included 837 patients receiving curative gastrectomy. This study showed the technique of performing peritoneal washings influenced cytology yield, however positive peritoneal cytology was not associated with decreased survival. Therefore, positive peritoneal cytology should not be considered an absolute contraindication to curatively intended gastrectomy.
publishDate 2025
dc.date.none.fl_str_mv 2025
2026
2026
2026
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/10230/72886
http://dx.doi.org/10.1016/j.soi.2025.100145
https://hdl.handle.net/10230/72886
url https://hdl.handle.net/10230/72886
http://dx.doi.org/10.1016/j.soi.2025.100145
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Surgical Oncology Insight. 2025;2(3):100145
dc.rights.none.fl_str_mv http://creativecommons.org/licenses/by/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Recercat. Dipósit de la Recerca de Catalunya
instname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
instname_str Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
reponame_str Recercat. Dipósit de la Recerca de Catalunya
collection Recercat. Dipósit de la Recerca de Catalunya
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869402536768700416
score 15,812429